when was glp-1 discovered Timeline of discovery and clinical development. (a) Key events in The Story of GLP-1: A

Discontinuing GLP-1 receptor agonist therapy leads to predictable physiological changes as drug levels decline and the pharmacological effects diminish

doi: 10.1002/oby.21200

Whilst there is limited specific research on preventing skin changes during GLP-1 therapy, established dermatological principles and weight management guidance provide a framework for supportive care

Energy balance mechanisms: Evaluation of hormone-linked metabolic processes

Riding the wave of success from obesity drugs like WEGOVY and ZEPBOUND , which together generated USD 10.8 billion in sales and, according to DelveInsight, are forecasted to hit USD 22.5 billion by 2034, pharmaceutical companies are scrambling to expand their pipelines